EUVIMEDEUVIMED entdecken
Multizentrische Studie

Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation

Felix Rudolph, Muhammed Gerçek, Johannes Kirchner, Maria Ivannikova, Kai P Friedrichs, Tanja K Rudolph, Volker Rudolph, Martin Andreas, Anna Bartunek, Philipp E Bartko, Varius Dannenberg

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-024-02549-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Felix Rudolph und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany. frudolph…. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Tricuspid Valve, Cardiac Catheterization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Within recent years, transcatheter tricuspid edge-to-edge repair (T-TEER) has emerged as a safe and effective treatment option in patients with secondary tricuspid regurgitation (TR). However, for primary TR, data on the robustness and durability of TR reduction 1 year following T-TEER is limited. METHODS: All consecutive patients treated with T-TEER for TR at two high-volume centers between September 2018 and December 2022 were enrolled in a registry. Primary TR was defined as tricuspid valve (TV) prolapse or flail TV leaflets as assessed by pre- and peri-interventional transesophageal echocardiography (TEE). RESULTS: 201 patients were included in this analysis, of whom 27 (13.4%) were classified as primary TR and 174 (86.6%) as TR of secondary origin. All-cause mortality during 1-year follow-up was reached by 50 patients (24.9%) [primary: 7 (25.9%), secondary: 43 (24.7%)], and 151 (75.1%) completed follow-up with transthoracic echocardiography (TTE). Patients' median age was 80 (76-83) years, 112 (55.7%) were female and 181 (90.1%) reported a New-York heart association functional class (NYHA-FC) of III or IV. The remaining baseline clinical and echocardiographic parameters were comparable between the groups, but secondary TR patients had a significantly higher TRI-SCORE (5 (4-8) vs. 7 (5-14), P = 0.010). In both groups, an immediate reduction of TR-Grade post-intervention was observed. This reduction was sustained at follow-up with 80.0% of the primary TR patients classified as moderate or less and 61.8% of the secondary TR patients. This translated to a significant improvement of NHYA-FC in both groups. Kaplan-Meier analysis revealed no differences regarding rates for all-cause mortality between the groups (P < 0.99). CONCLUSION: T-TEER achieves a robust TR reduction in primary TR patients 1 year after intervention with noninferior clinical results to treatment for secondary TR with regards to mortality, re-hospitalization, and NYHA-FC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyTricuspid ValveCardiac CatheterizationHumansFemaleMaleAgedAged, 80 and overRegistriesTreatment OutcomeEchocardiography, TransesophagealTime FactorsFollow-Up StudiesRetrospective Studies

Stichwörter der Autor:innen

Flail leafletPrimary tricuspid regurgitationProlapseRight-ventricular remodelingTranscatheter edge-to-edge repairTransesophageal echocardiography

Autor:innen und Institutionen

  • Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany. frudolph@hdz-nrw.de.
  • Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
  • Division of Cardiac, Thoracic, Vascular Anesthesia and Intensive Care Medicine, Department of Anesthesiology, General Intensive Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.
  • Department for Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria. philippemanuel.bartko@meduniwien.ac.at.
  • Department for Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria.

Zitieren

APA

Rudolph, F., Gerçek, M., Kirchner, J., Ivannikova, M., Friedrichs, K. P., Rudolph, T. K., Rudolph, V., Andreas, M., Bartunek, A., Bartko, P. E., & Dannenberg, V. (2025). Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02549-5

Vancouver

Rudolph F, Gerçek M, Kirchner J, Ivannikova M, Friedrichs KP, Rudolph TK, et al. Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02549-5

BibTeX
@article{Rudolph2025,
  author = {Rudolph, Felix and Gerçek, Muhammed and Kirchner, Johannes and Ivannikova, Maria and Friedrichs, Kai P and Rudolph, Tanja K and Rudolph, Volker and Andreas, Martin and Bartunek, Anna and Bartko, Philipp E and Dannenberg, Varius},
  title = {Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-024-02549-5}
}
Kostenlos starten →